The FDA-approved GLP-1 medications come in injectable pens with precise dosing, whereas compounded GLP-1 drugs typically come in a vial with a syringe that can offer more flexibility for microdosing, but also opens up the chance for taking too much or too little medication
These medications mimic the activity of natural hormone glucagon-like peptide-1 (GLP-1) receptors located in the pancreas, brain, and gut to slow gastric emptying, increase insulin secretion, reduce appetite, and improve blood glucose levels
The Bridge program is slated to run until the end of 2027, prompting providers to raise concerns about what will happen if the government does not extend it as people typically regain the weight they lost after stopping a GLP-1
Read about NCLs impact Script Your Future saved my life Cincinnati resident Charles, 45, lost his computer business and health insurance during a time of economic downturn
One glowing Ro review on Reddit notes that the educational content is interesting and insightful, the team is "responsive, helpful, and flexible, and the service is fast
